Literature DB >> 19197262

Absence of association between the INSIG2 gene polymorphism (rs7566605) and obesity in the European Youth Heart Study (EYHS).

Karani S Vimaleswaran1, Paul W Franks, Soren Brage, Luis B Sardinha, Lars B Andersen, Nicholas J Wareham, Ulf Ekelund, Ruth J F Loos.   

Abstract

The first genome-wide association study for BMI identified a polymorphism, rs7566605, 10 kb upstream of the insulin-induced gene 2 (INSIG2) transcription start site, as the most significantly associated variant in children and adults. Subsequent studies, however, showed inconsistent association of this polymorphism with obesity traits. This polymorphism has been hypothesized to alter INSIG2 expression leading to inhibition of fatty acid and cholesterol synthesis. Hence, we investigated the association of the INSIG2 rs7566605 polymorphism with obesity- and lipid-related traits in Danish and Estonian children (930 boys and 1,073 girls) from the European Youth Heart Study (EYHS), a school-based, cross-sectional study of pre- and early pubertal children. The association between the polymorphism and obesity traits was tested using additive and recessive models adjusted for age, age-group, gender, maturity and country. Interactions were tested by including the interaction terms in the model. Despite having sufficient power (98%) to detect the previously reported effect size for association with BMI, we did not find significant effects of rs7566605 on BMI (additive, P = 0.68; recessive, P = 0.24). Accordingly, the polymorphism was not associated with overweight (P = 0.87) or obesity (P = 0.34). We also did not find association with waist circumference (WC), sum of four skinfolds, or with total cholesterol, triglycerides, low-density lipoprotein, or high-density lipoprotein. There were no gender-specific (P = 0.55), age-group-specific (P = 0.63) or country-specific (P = 0.56) effects. There was also no evidence of interaction between genotype and physical activity (P = 0.95). Despite an adequately powered study, our findings suggest that rs7566605 is not associated with obesity-related traits and lipids in the EYHS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197262     DOI: 10.1038/oby.2008.650

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

1.  A tagging SNP in INSIG2 is associated with obesity-related phenotypes among Samoans.

Authors:  Ranjan Deka; Ling Xu; Prodipto Pal; Palanitina T Toelupe; Tuiasina S Laumoli; Huifeng Xi; Ge Zhang; Daniel E Weeks; Stephen T McGarvey
Journal:  BMC Med Genet       Date:  2009-12-22       Impact factor: 2.103

2.  INSIG2 variants, dietary patterns and metabolic risk in Samoa.

Authors:  A Baylin; R Deka; J Tuitele; S Viali; D E Weeks; S T McGarvey
Journal:  Eur J Clin Nutr       Date:  2012-09-12       Impact factor: 4.016

3.  Association of INSIG2 polymorphism with overweight and LDL in children.

Authors:  Anne-Marie Kaulfers; Ranjan Deka; Lawrence Dolan; Lisa J Martin
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

4.  Common Genetic Variant of insig2 Gene rs7566605 Polymorphism Is Associated with Severe Obesity in North India

Authors:  Jai Prakash; Balraj Mittal; Srivastava Apurva; Awasthi Shally; Srivastava Pranjal; Srivastava Neena
Journal:  Iran Biomed J       Date:  2017-05-21

5.  The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts.

Authors:  Jan Bressler; Myriam Fornage; Craig L Hanis; Wen Hong Linda Kao; Cora E Lewis; Ruth McPherson; Robert Dent; Thomas H Mosley; Len A Pennacchio; Eric Boerwinkle
Journal:  BMC Med Genet       Date:  2009-06-12       Impact factor: 2.103

6.  Association analyses of the INSIG2 polymorphism in the obesity and cholesterol levels of Korean populations.

Authors:  Seongwon Cha; Imhoi Koo; Sun Mi Choi; Byung Lae Park; Kil Soo Kim; Jae-Ryong Kim; Hyoung Doo Shin; Jong Yeol Kim
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.